Two-Port Robotic Laparoscopic Hysterectomy. J Minim Invasive Gynecol 2021. [DOI: 10.1016/j.jmig.2021.09.315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]

A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793). Ann Oncol 2021;32:1045-1046. [PMID: 33932502 DOI: 10.1016/j.annonc.2021.04.013] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2021] [Revised: 04/21/2021] [Accepted: 04/22/2021] [Indexed: 01/21/2023]  Open

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab-govitecan. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]

Chemotherapy choice and impact on survival of patients with carcinosarcoma of the ovary: A retrospective review. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]

The PARP inhibitor niraparib demonstrates preclinical activity against HRD-deficient carcinosarcomas. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]

Robotic Colostomy Take-Down. J Minim Invasive Gynecol 2019. [DOI: 10.1016/j.jmig.2019.09.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]

The combination of olaparib (Poly ADP-ribose polymerase inhibitor) with neratinib (pan-HER inhibitor) is synergistic in epithelial ovarian carcinoma overexpressing HER2. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]

Whole exome sequencing (WES) reveals novel therapeutic targets in cervical cancer. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]

Impact of carboplatin hypersensitivity and desensitization on overall survival in patients with recurrent ovarian cancer. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]

Primary cytoreductive surgery versus neoadjuvant chemotherapy for advanced-stage uterine malignancies. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]

Intravenous Leiomyomatosis of the Uterus Extending into the Ovarian Vein. J Minim Invasive Gynecol 2018. [DOI: 10.1016/j.jmig.2018.09.229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]

Remarkable in vitro and in vivo activity of IMGN853, an antibody-drug conjugate targeting folate receptor alpha linked to the tubulin-disrupting maytansinoid DM4, in biologically aggressive (type II) endometrial cancers. Gynecol Oncol 2018. [DOI: 10.1016/j.ygyno.2018.04.159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]

The impact of tumor fragments in the lumen of fallopian tubes on recurrence and survival in type I and type II endometrial cancers. Gynecol Oncol 2017. [DOI: 10.1016/j.ygyno.2017.03.300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]

Carboplatin hypersensitivity correlates with mutations in the DNA repair enzyme BRCA. Gynecol Oncol 2017. [DOI: 10.1016/j.ygyno.2017.03.265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]